業績

学術論文等

  • Masuda T, Hirata T, Sakamoto T, Tsubata Y, Ishihara E, Kozuki T, Shoda H, Motonaga M, Yoshida T, Fukutani M, Tsuji-Takayama K, Tamura A, Amagase H, Fujihara H, Aoki G, Akita T, Orihashi Y, Miyata T, Hattori N. Treatment rationale and protocol design: an investigator-initiated phase II study of combination treatment of nivolumab and TM5614, a PAI-1 inhibitor for previously treated patients with non-small cell lung cancer. J Thorac Dis, 2024; 16 (5): 3381-3388.
  • Mizuno Y, Komatsu K, Tokumo K, Okada N, Onoe H, Okumichi H, Hirooka K, Aoki G, Miura Y and Kiuchi Y. Safety and Efficacy of the Rho-Kinase Inhibitor (Ripasudil) in Bleb Needling after Trabeculectomy: A Prospective Multicenter Study. J Clin Med 2024, 13(1), 75 https://doi.org/10.3390/jcm13010075
  • Ohira M, Aoki G, Orihashi Y, Yoshimura K, Toshima T, Hatano E, Eguchi S, Hibi T, Hasegawa K, Umeda Y, Hashimoto T, Hasegawa Y, Nobori S, Ogura Y, Nitta H, Egawa H, Eguchi H, Takada Y, Ueda Y, Kasahara M, Kawachi S, Soejima Y, Tokushige K, Nagano H, Haga H, Fukumoto T, Mochida S, Umeshita K, Ohdan H. The Japanese Liver Transplantation Society “Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort study” BJS Open, Volume 8, Issue 4, August 2024, zrae079, https://doi.org/10.1093/bjsopen/zrae079
  • Hirooka K, Higashide T, Sakaguchi K, Udagawa S, Sugiyama K, Oki K, Kometani M, Yoneda T, Fukunaga K, Akita T, Baba T and Kiuchi Y. Prevalence of normal-tension glaucoma in patients with primary aldosteronism. Am J Ophthalmol Sep 14:269 339-345, doi 10.1016/j.ajo.2024.09.014. 2024.
  • Watanabe K, Hikichi H, Imamura K, Sakuraya A, Yoshikawa T, Izawa S, Eguchi H, Inoue A, Yoshida K, Orihashi Y and Tsutsumi A. Multifaceted ORganizational InterventiONs (M‑ORION) project for prevention of depression and anxiety among workers: study protocol for a five‑arm cluster randomized controlled trial. BMC Public Health (2024) 24:601. https://doi.org/10.1186/s12889-024-18112-w
  • 齋藤哲雄、今野伸樹、 武冨奈菜美、 室谷健太.臨床試験に付随した医療経済評価の統計解析.計量生物学45(2)、23-55 2024.

学会/研修会等での発表等

  • Masuda T, Hirata T, Sakamoto T, Tsubata Y, Ichihara E, Kozuki T, Shoda H, Fukugawa E, Yosida T, Fukutani M, Tsuji-Takayama K, Orihashi Y, Hattori N. An Investigator-Initiated Phase II Study of Combination Treatment of Nivolumab and TM5614, A PAI-1 Inhibitor for Previously Treated NSCLC. World Conference of Lung Cancer2024 9/7-10. 2024
  • 松本 頼明、秋田 智之、横町 和志、藤岡 知加子、木口 雅夫、粟井 和夫.造影CTにおけるセンサーデバイスによる多量血管外漏出予防の実現可能性:観察研究.日本CT技術学会第12回学術大会.2024
  • 武冨奈菜美、江村剛志.固定効果メタアナリシスにおける共通平均の推定量の一致性.2024年度日本計量生物学会年会
  • Taketomi N. Confidence interval for normal means in meta-analysis based on a pretest estimator 2024年度統計関連学会連合大会

その他

  • Kishita R, et al. Fall risk prediction ability in rehabilitation professionals: structural equation modeling using time pressure test data for Kiken-Yochi Training. Sports Medicine and Rehabilitation, January 3, 2024 (Acknowledgements to Orihashi Y and Aoki G) https://peerj.com/articles/16724/
  • Kohada Y, et al. Prognostic Impact of the Modified 5-Item Frailty Index After Radical Nephroureterectomy in Patients With Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study. Clinical Genitourinary Cancer, Volume 22, Issue 2, April 2024, Pages 322-329.e3. (Acknowledgements to Aoki G and Orihashi Y) https://www.sciencedirect.com/science/article/pii/S1558767323002665
  • Tanahashi H, et al. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis. Respiratory Research, Volume 25, article number 195, (2024) (Acknowledgements to Aoki G and Akita T) https://link.springer.com/article/10.1186/s12931-024-02825-y
  • Shigematsu H, et al. A nomogram to predict the pathological complete response in patients with breast cancer based on the TILs-US score. Japanese Journal of Clinical Oncology, Volume 54, Issue 9, September 2024, Pages 967–974. (Clinical Research Center in Hiroshima for assistance with the statistical analysis) https://doi.org/10.1093/jjco/hyae076
  • Ohira M, Imaoka K, Bekki T, Sato K, Imaoka Y, Nakano R, Yano T, Doskali M, Shimizu S, Chogahara I, Sato Saki, Nakamura M, Tanaka Y and Ohdan H. Donor Age Correlates With Liver-Resident Natural Killer Cell Activity in Adoptive Immunotherapy Using Donor Liver Natural Killer Cells in Liver Transplantation. Transplant Proc. 2024;56(3):667-71.